Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies
<p>This systematic review aims to summarise the clinical outcomes of l-glutamine, crizanlizumab, and voxelotor in the treatment of sickle cell disease (SCD) based on clinical trials and real-world data and to identify any gaps in the observations. The review identified 97 studies reporting dat...
محفوظ في:
| المؤلف الرئيسي: | Mohamed Yassin (4166515) (author) |
|---|---|
| مؤلفون آخرون: | Caterina Minniti (21189398) (author), Nirmish Shah (6672725) (author), Salam Alkindi (11601856) (author), Fateen Ata (12217764) (author), Mohammed Qari (21189401) (author), Abdullah Al Zayed (21189404) (author), Jaffer Altooq (18186850) (author), Mona Al Rasheed (12040519) (author), Maria Domenica Capellini (21189407) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
حسب: Awni Alshurafa (15468195)
منشور في: (2022) -
Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar’s healthcare perspective
حسب: Ahmad M Adel (21767351)
منشور في: (2024) -
Knowledge, attitude, and practice of physicians regarding pain management in patients with Sickle cell disease
حسب: Abdellatif Ismail (14182309)
منشور في: (2023) -
Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: A case report
حسب: Mohammed Abdulgayoom (14777791)
منشور في: (2024) -
The role of preoperative transfusion in sickle cell disease, a systematic review and meta-analysis
حسب: Yasamin Abdu (15899155)
منشور في: (2024)